161 related articles for article (PubMed ID: 28623448)
1. Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma.
Nakata Y; Hanai N; Nishikawa D; Suzuki H; Koide Y; Fukuda Y; Nomura M; Kodaira T; Shimizu T; Hasegawa Y
Int J Clin Oncol; 2017 Dec; 22(6):1034-1041. PubMed ID: 28623448
[TBL] [Abstract][Full Text] [Related]
2. Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function.
Nobacht A; Meijer TWH; Oosting SF; van der Vegt B; Wedman J; Halmos GB; Plaat BEC
J Laryngol Otol; 2024 Jun; 138(6):672-678. PubMed ID: 38235588
[TBL] [Abstract][Full Text] [Related]
3. From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer.
Spector ME; Rosko AJ; Swiecicki PL; Chad Brenner J; Birkeland AC
Oral Oncol; 2018 Nov; 86():200-205. PubMed ID: 30409302
[TBL] [Abstract][Full Text] [Related]
4. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
Li ZD; Lu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
[No Abstract] [Full Text] [Related]
5. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
[TBL] [Abstract][Full Text] [Related]
6. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
[TBL] [Abstract][Full Text] [Related]
7. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
[TBL] [Abstract][Full Text] [Related]
8. Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer.
Vainshtein JM; Wu VF; Spector ME; Bradford CR; Wolf GT; Worden FP
Expert Rev Anticancer Ther; 2013 Sep; 13(9):1053-64. PubMed ID: 24053204
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.
Janoray G; Pointreau Y; Alfonsi M; Sire C; Geoffrois L; de Raucourt D; Bardet E; Calais MH; Garaud P; Calais G
Eur J Cancer; 2020 Jul; 133():86-93. PubMed ID: 32454417
[TBL] [Abstract][Full Text] [Related]
11. Pyriform sinus squamous cell carcinoma: oncological outcomes in good responders of induction chemotherapy-based larynx preservation protocols.
Vourexakis Z; Le Ridant AM; Dulguerov P; Janot F
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1725-31. PubMed ID: 24854231
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
[TBL] [Abstract][Full Text] [Related]
13. Outcomes from chemoradiotherapy for patients with esophageal cancer.
Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC
Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614
[TBL] [Abstract][Full Text] [Related]
14. Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol.
León X; Valero C; Rovira C; Rodriguez C; López M; García-Lorenzo J; Quer M
Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2581-2587. PubMed ID: 28349204
[TBL] [Abstract][Full Text] [Related]
15. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.
Bidoli P; Bajetta E; Stani SC; De CD; Santoro A; Valente M; Zucali R; Valagussa P; Ravasi G; Bonadonna G
Cancer; 2002 Jan; 94(2):352-61. PubMed ID: 11900221
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
[TBL] [Abstract][Full Text] [Related]
17. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for Cervical Esophageal Squamous Cell Carcinoma.
Kwong DLW; Chan WWL; Lam KO
Methods Mol Biol; 2020; 2129():295-305. PubMed ID: 32056186
[TBL] [Abstract][Full Text] [Related]
19. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
[TBL] [Abstract][Full Text] [Related]
20. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion.
Worden FP; Moyer J; Lee JS; Taylor JM; Urba SG; Eisbruch A; Teknos TN; Chepeha DB; Prince ME; Hogikyan N; Lassig AA; Emerick K; Mukherji S; Hadjiski L; Tsien CI; Miller TH; Wallace NE; Mason HL; Bradford CR; Wolf GT
Laryngoscope; 2009 Aug; 119(8):1510-7. PubMed ID: 19504552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
